Proactiveinvestors USA & Canada Orgenesis https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada Orgenesis RSS feed en Wed, 27 Jan 2021 18:37:38 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Orgenesis leads the charge at an exciting time for cell and gene therapy https://ca.proactiveinvestors.com/companies/news/935582/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-and-gene-therapy-935582.html Thu, 03 Dec 2020 11:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/935582/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-and-gene-therapy-935582.html Orgenesis sees 3Q revenue rise by 40%, driven by rapid progress in its point-of-care network https://ca.proactiveinvestors.com/companies/news/933276/orgenesis-sees-3q-revenue-rise-by-40-driven-by-rapid-progress-in-its-point-of-care-network-933276.html Thu, 05 Nov 2020 14:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/933276/orgenesis-sees-3q-revenue-rise-by-40-driven-by-rapid-progress-in-its-point-of-care-network-933276.html Orgenesis completes acquisition of Koligo Therapeutics and acquires assets of Tissue Genesis LLC https://ca.proactiveinvestors.com/companies/news/931804/orgenesis-completes-acquisition-of-koligo-therapeutics-and-acquires-assets-of-tissue-genesis-llc-931804.html Mon, 19 Oct 2020 14:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/931804/orgenesis-completes-acquisition-of-koligo-therapeutics-and-acquires-assets-of-tissue-genesis-llc-931804.html Orgenesis in deal to acquire regenerative medicine company Koligo Therapeutics https://ca.proactiveinvestors.com/companies/news/930249/orgenesis-in-deal-to-acquire-regenerative-medicine-company-koligo-therapeutics-930249.html Tue, 29 Sep 2020 13:28:00 -0400 https://ca.proactiveinvestors.com/companies/news/930249/orgenesis-in-deal-to-acquire-regenerative-medicine-company-koligo-therapeutics-930249.html Orgenesis Inc outlines ways in which the group is aiming to combat the coronavirus https://ca.proactiveinvestors.com/companies/news/929230/orgenesis-inc-outlines-ways-in-which-the-group-is-aiming-to-combat-the-coronavirus-929230.html Wed, 16 Sep 2020 12:07:00 -0400 https://ca.proactiveinvestors.com/companies/news/929230/orgenesis-inc-outlines-ways-in-which-the-group-is-aiming-to-combat-the-coronavirus-929230.html Biopharmaceuticals battling COVID-19 pandemic to connect with investors via Proactive One2One Investor Forum on September 10 https://ca.proactiveinvestors.com/companies/news/928342/biopharmaceuticals-battling-covid-19-pandemic-to-connect-with-investors-via-proactive-one2one-investor-forum-on-september-10-928342.html Wed, 09 Sep 2020 20:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/928342/biopharmaceuticals-battling-covid-19-pandemic-to-connect-with-investors-via-proactive-one2one-investor-forum-on-september-10-928342.html Orgenesis leads the charge at an exciting time for cell and gene therapy https://ca.proactiveinvestors.com/companies/news/918903/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-and-gene-therapy-918903.html Fri, 04 Sep 2020 11:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/918903/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-and-gene-therapy-918903.html Orgenesis collabs with dermatology research organization on topical Ranpirnase formation to treat HPV symptoms https://ca.proactiveinvestors.com/companies/news/927169/orgenesis-collabs-with-dermatology-research-organization-on-topical-ranpirnase-formation-to-treat-hpv-symptoms-927169.html Thu, 20 Aug 2020 13:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/927169/orgenesis-collabs-with-dermatology-research-organization-on-topical-ranpirnase-formation-to-treat-hpv-symptoms-927169.html Orgenesis touts 2Q revenue jump from its POCare network, advances coronavirus vaccine platform https://ca.proactiveinvestors.com/companies/news/926160/orgenesis-touts-2q-revenue-jump-from-its-pocare-network-advances-coronavirus-vaccine-platform-926160.html Fri, 07 Aug 2020 14:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/926160/orgenesis-touts-2q-revenue-jump-from-its-pocare-network-advances-coronavirus-vaccine-platform-926160.html Orgenesis teams up with European firm Educell on T-cell research projects https://ca.proactiveinvestors.com/companies/news/924170/orgenesis-teams-up-with-european-firm-educell-on-t-cell-research-projects-924170.html Tue, 14 Jul 2020 12:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/924170/orgenesis-teams-up-with-european-firm-educell-on-t-cell-research-projects-924170.html Orgenesis to collaborate with Fortune 500 firm Leidos on potential coronavirus treatment https://ca.proactiveinvestors.com/companies/news/922467/orgenesis-to-collaborate-with-fortune-500-firm-leidos-on-potential-coronavirus-treatment-922467.html Mon, 22 Jun 2020 14:58:00 -0400 https://ca.proactiveinvestors.com/companies/news/922467/orgenesis-to-collaborate-with-fortune-500-firm-leidos-on-potential-coronavirus-treatment-922467.html Orgenesis launches BioShield Program to fight spread of viruses such as coronavirus https://ca.proactiveinvestors.com/companies/news/921610/orgenesis-launches-bioshield-program-to-fight-spread-of-viruses-such-as-coronavirus-921610.html Wed, 10 Jun 2020 14:21:00 -0400 https://ca.proactiveinvestors.com/companies/news/921610/orgenesis-launches-bioshield-program-to-fight-spread-of-viruses-such-as-coronavirus-921610.html Orgenesis to conduct clinical study of tumor-infiltrating lymphocytes with Israeli public hospital https://ca.proactiveinvestors.com/companies/news/920863/orgenesis-to-conduct-clinical-study-of-tumor-infiltrating-lymphocytes-with-israeli-public-hospital-920863.html Mon, 01 Jun 2020 16:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/920863/orgenesis-to-conduct-clinical-study-of-tumor-infiltrating-lymphocytes-with-israeli-public-hospital-920863.html Orgenesis launches research collaboration with Madrid hospital to establish point-of-care center https://ca.proactiveinvestors.com/companies/news/920290/orgenesis-launches-research-collaboration-with-madrid-hospital-to-establish-point-of-care-center-920290.html Fri, 22 May 2020 14:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/920290/orgenesis-launches-research-collaboration-with-madrid-hospital-to-establish-point-of-care-center-920290.html Orgenesis unveils plans to repurchase up to $10 million in stock https://ca.proactiveinvestors.com/companies/news/919726/orgenesis-unveils-plans-to-repurchase-up-to-10-million-in-stock-919726.html Fri, 15 May 2020 13:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/919726/orgenesis-unveils-plans-to-repurchase-up-to-10-million-in-stock-919726.html Orgenesis launches new cell-based vaccine platform targeting COVID-19 virus https://ca.proactiveinvestors.com/companies/news/919515/orgenesis-launches-new-cell-based-vaccine-platform-targeting-covid-19-virus-919515.html Wed, 13 May 2020 19:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/919515/orgenesis-launches-new-cell-based-vaccine-platform-targeting-covid-19-virus-919515.html Orgenesis sees 1Q revenue rocket driven by its Cell and Gene Therapy Biotech platform https://ca.proactiveinvestors.com/companies/news/919275/orgenesis-sees-1q-revenue-rocket-driven-by-its-cell-and-gene-therapy-biotech-platform-919275.html Mon, 11 May 2020 13:35:00 -0400 https://ca.proactiveinvestors.com/companies/news/919275/orgenesis-sees-1q-revenue-rocket-driven-by-its-cell-and-gene-therapy-biotech-platform-919275.html Orgenesis boss Vered Caplan makes top 20 list of inspirational leaders in advanced medicine https://ca.proactiveinvestors.com/companies/news/918442/orgenesis-boss-vered-caplan-makes-top-20-list-of-inspirational-leaders-in-advanced-medicine-918442.html Wed, 29 Apr 2020 17:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/918442/orgenesis-boss-vered-caplan-makes-top-20-list-of-inspirational-leaders-in-advanced-medicine-918442.html Orgenesis closes acquisition of Tamir Biotechnology and its antiviral platform ranpiranse https://ca.proactiveinvestors.com/companies/news/918192/orgenesis-closes-acquisition-of-tamir-biotechnology-and-its-antiviral-platform-ranpiranse-918192.html Mon, 27 Apr 2020 13:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/918192/orgenesis-closes-acquisition-of-tamir-biotechnology-and-its-antiviral-platform-ranpiranse-918192.html NA Proactive news snapshot: Mandalay Resources, Ideanomics, Aurania, Resources, Algernon Pharmaceuticals, GR Silver Mining, Metalla Royalty and Streaming UPDATE … https://ca.proactiveinvestors.com/companies/news/917097/na-proactive-news-snapshotmandalay-resources-ideanomics-aurania-resources-algernon-pharmaceuticals-gr-silver-mining-metalla-royalty-and-streaming-update--917097.html Mon, 13 Apr 2020 21:04:00 -0400 https://ca.proactiveinvestors.com/companies/news/917097/na-proactive-news-snapshotmandalay-resources-ideanomics-aurania-resources-algernon-pharmaceuticals-gr-silver-mining-metalla-royalty-and-streaming-update--917097.html Orgenesis to acquire assets of Tamir Biotechnology and its anti-viral platform ranpirnase for $19M https://ca.proactiveinvestors.com/companies/news/917094/orgenesis-to-acquire-assets-of-tamir-biotechnology-and-its-anti-viral-platform-ranpirnase-for-19m-917094.html Mon, 13 Apr 2020 13:35:00 -0400 https://ca.proactiveinvestors.com/companies/news/917094/orgenesis-to-acquire-assets-of-tamir-biotechnology-and-its-anti-viral-platform-ranpirnase-for-19m-917094.html Orgenesis partners with Belgium's RevaTis to develop stem cells for therapeutic use https://ca.proactiveinvestors.com/companies/news/916959/orgenesis-partners-with-belgium-s-revatis-to-develop-stem-cells-for-therapeutic-use-916959.html Wed, 08 Apr 2020 16:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/916959/orgenesis-partners-with-belgium-s-revatis-to-develop-stem-cells-for-therapeutic-use-916959.html Orgenesis and ExcellaBio develop a breakthrough manufacturing process for bioxomes https://ca.proactiveinvestors.com/companies/news/916247/orgenesis-and-excellabio-develop-a-breakthrough-manufacturing-process-for-bioxomes-916247.html Tue, 31 Mar 2020 16:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/916247/orgenesis-and-excellabio-develop-a-breakthrough-manufacturing-process-for-bioxomes-916247.html Orgenesis CEO Vered Caplan says R&D labs still operating during coronavirus pandemic https://ca.proactiveinvestors.com/companies/news/916125/orgenesis-ceo-vered-caplan-says-rd-labs-still-operating-during-coronavirus-pandemic-916125.html Mon, 30 Mar 2020 13:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/916125/orgenesis-ceo-vered-caplan-says-rd-labs-still-operating-during-coronavirus-pandemic-916125.html NA Proactive news snapshot: Ipsidy, Co-Diagnostics, Antibe Therapeutics, The Green Organic Dutchman UPDATE … https://ca.proactiveinvestors.com/companies/news/914664/na-proactive-news-snapshot-ipsidy-co-diagnostics-antibe-therapeutics-the-green-organic-dutchman-update--914664.html Tue, 10 Mar 2020 21:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/914664/na-proactive-news-snapshot-ipsidy-co-diagnostics-antibe-therapeutics-the-green-organic-dutchman-update--914664.html Orgenesis sees fiscal 2019 revenue surge by 78% to a record $33.3M https://ca.proactiveinvestors.com/companies/news/914659/orgenesis-sees-fiscal-2019-revenue-surge-by-78-to-a-record-333m-914659.html Tue, 10 Mar 2020 13:59:00 -0400 https://ca.proactiveinvestors.com/companies/news/914659/orgenesis-sees-fiscal-2019-revenue-surge-by-78-to-a-record-333m-914659.html Orgenesis teams up with Johns Hopkins University to develop gene therapies with its POCare platform https://ca.proactiveinvestors.com/companies/news/913249/orgenesis-teams-up-with-johns-hopkins-university-to-develop-gene-therapies-with-its-pocare-platform-913249.html Wed, 19 Feb 2020 14:35:00 -0500 https://ca.proactiveinvestors.com/companies/news/913249/orgenesis-teams-up-with-johns-hopkins-university-to-develop-gene-therapies-with-its-pocare-platform-913249.html Orgenesis stock flies as it completes sale of Masthercell subsidiary to get $127M pay day https://ca.proactiveinvestors.com/companies/news/912677/orgenesis-stock-flies-as-it-completes-sale-of-masthercell-subsidiary-to-get-127m-pay-day-912677.html Tue, 11 Feb 2020 14:56:00 -0500 https://ca.proactiveinvestors.com/companies/news/912677/orgenesis-stock-flies-as-it-completes-sale-of-masthercell-subsidiary-to-get-127m-pay-day-912677.html Orgenesis to get $127M from sale of Masthercell subsidiary https://ca.proactiveinvestors.com/companies/news/912074/orgenesis-to-get-127m-from-sale-of-masthercell-subsidiary-912074.html Mon, 03 Feb 2020 16:50:00 -0500 https://ca.proactiveinvestors.com/companies/news/912074/orgenesis-to-get-127m-from-sale-of-masthercell-subsidiary-912074.html Orgenesis looks to raise $9.24M in orchestrated private placement https://ca.proactiveinvestors.com/companies/news/911158/orgenesis-looks-to-raise-924m-in-orchestrated-private-placement-911158.html Tue, 21 Jan 2020 13:52:00 -0500 https://ca.proactiveinvestors.com/companies/news/911158/orgenesis-looks-to-raise-924m-in-orchestrated-private-placement-911158.html